Company intelligence / Profile preview
Primo Biotechnology
Taipei, Taipei City, Taiwanprimobt.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Currently conducting a multicenter clinical trial of 18F-PSMA-1007 in Taiwan to evaluate its diagnostic performance in different-stage prostate cancer patients[3]
- Therapeutic areas
- Oncology
- Modalities
- RadiopharmaceuticalsRadioligand theranostics (RLT)
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Beyond the preview
Go deeper on Primo Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Primo Biotechnology.